Abrine Elicits Liver Carcinoma Immunity and Enhances Antitumor Efficacy of Immune Checkpoint Blockade by Modulating PD-L1 Signaling

BACKGROUND: Liver cancer is the most malignant type of human malignancies. In recent years, immune therapy that targets the immune check points such as programmed cell death ligand 1 (PD-L1) has achieve great success. Abrine is the dominant alkaloid in Abrus cantoniensis and Abrus precatorius Linn....

Descripción completa

Detalles Bibliográficos
Autor principal: Zhang, Shaowu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119764/
https://www.ncbi.nlm.nih.gov/pubmed/35602291
http://dx.doi.org/10.1155/2022/7609676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119764/
https://www.ncbi.nlm.nih.gov/pubmed/35602291
http://dx.doi.org/10.1155/2022/7609676

Ejemplares similares